| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
3 Warren Buffett Stocks I Absolutely, Positively Wouldn't Buy Right Now
https://www.fool.com/investing/2020/04/05/3-warren-buffett-stocks-i-absolutely-positively-wo.aspx?source=iedfolrf0000001
Apr 05, 2020 - The Oracle of Omaha owns some fantastic stocks in his Berkshire Hathaway portfolio. These aren't in the group.
0
Teva prevails in migraine patent dispute with Lilly; shares up 9%
https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-lilly-shares-up-9?utm_source=feed_news_all&utm_medium=referral
Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
0
Teva prevails in migraine patent dispute; shares up 9%
https://seekingalpha.com/news/3556858-teva-prevails-in-migraine-patent-dispute-shares-up-9?source=feed_sector_healthcare
Mar 31, 2020 - The USPTO's Patent Trial and Appeal Board has upheld three patents protecting Teva Pharmaceutical Industries' (TEVA +9.0%) migraine med Ajovy (fremanezumab-vfrm) that were challenged by Eli Lilly (LLY
0
3 Ridiculously Cheap Buffett Stocks to Buy Now
https://www.fool.com/investing/2020/03/31/3-ridiculously-cheap-buffett-stocks-to-buy-now.aspx?source=iedfolrf0000001
Mar 31, 2020 - It's been a while since the Oracle of Omaha had bargains like this in his portfolio.
0
FDA Authorizes Use of Old Malaria Drugs to Treat COVID-19
https://www.fool.com/investing/2020/03/30/fda-authorizes-use-of-old-malaria-drugs-to-treat-c.aspx?source=iedfolrf0000001
Mar 30, 2020 - Despite scant clinical evidence that they work, the FDA issued its first emergency use authorization for therapeutic products to treat the novel coronavirus.
0
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma
http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know
http://www.zacks.com/stock/news/837115/teva-pharmaceutical-industries-ltd-teva-gains-but-lags-market-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-837115
Mar 26, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session.
0
Teva Pharmaceuticals Near 20-Year Lows
https://seekingalpha.com/article/4332825-teva-pharmaceuticals-near-20-year-lows?source=feed_tag_israel
Mar 18, 2020 -
0
Pages: 1
Page 1